The Psychedelic Therapy Podcast25 Helmi 2022

Shelby Hartman (DoubleBlind): The Philosophy of Psychedelic Journalism

Where do you get your psychedelic news? DoubleBlind is a leading media company and magazine that has teamed up with experts in the field to provide informative and educational news, courses, and webinars in the psychedelic space. Today on the show we are speaking with DoubleBlind Co-Founder and CEO Shelby Hartman.

We begin our conversation with the inception of the magazine, the meaning behind the name and DoubleBlind’s most popular articles. Shelby shares how DoubleBlind runs as a business, through its courses, memberships, and webinars, as well as the ongoing challenges faced by psychedelic businesses on social media platforms. We close with the future of DoubleBlind magazine and the psychedelic community at large.

Shelby Hartman is the co-founder and Editor-in-Chief of DoubleBlind Magazine. Her work has appeared in VICE, Quartz, the Huffington Post, and Rolling Stone, among others. After working in broadcast news production for CBS News, Shelby transitioned to magazine writing, working as an editor at Pasadena Magazine. She later worked as a columnist at LA Weekly and an editor at the cannabis media company, Herb.

Links

Timestamps

:01 The idea behind DoubleBlind Magazine
:09 Shelby’s intro to psychedelics and philosophies
:20 DoubleBlind’s audience, the reason behind the name, and top articles
:32 DoubleBlind Magazine as a business and challenges faced across digital platforms
:43 DoubleBlind’s membership, the future of the magazine, and the psychedelic community at large

Tämä jakso on lisätty Podme-palveluun avoimen RSS-syötteen kautta eikä se ole Podmen omaa tuotantoa. Siksi jakso saattaa sisältää mainontaa.

Jaksot(64)

Ismail Lourido Ali (MAPS): The Work No Executive Order Can Do

"We can pass 10 executive orders. We can put $500 million for drug development. And if we don't have people who are willing to hold that space... we're not going to get anywhere." - Ismail Lourido Ali...

21 Huhti 1h 10min

Robin Arnott & Sandeep Prakash: Training for Psychedelic Surrender

Can we practice the art of surrender before the first dose?Today on the show Robin Arnott and Dr. Sandeep Prakash explain how SoundSelf evolved from a VR curiosity into a clinically oriented tool that...

25 Huhti 202555min

Joshua White: Who You Gonna Call? Fireside

Imagine you’re in the middle of a psychedelic journey—things are getting intense, and you just need someone to talk to. That’s whereFireside Project comes in. As the world’s first psychedelic peer sup...

13 Helmi 20251h 14min

Tom Feegel: Ibogaine for Cognitive Enhancement

A month ago, I had the privilege of visiting Beond in Cancun, Mexico to experience an ibogaine treatment for cognitive enhancement. Today, I’m joined by Beond CEO Tom Feegel to discuss how this remark...

27 Tammi 20251h 6min

Juan Pablo Capello: A Wakeup Call for Ketamine Telehealth Companies

Today, I’m joined by Juan Pablo Capello, co-founder and former CEO of New Life Health, a telehealth ketamine therapy service launched in 2021. Juan Pablo has raised concerns about low standards of car...

20 Marras 20241h 4min

Natalie Lyla Ginsberg (MAPS): The FDA, MDMA, and the Future of Psychedelic Therapy

Today, we’re exploring a critical issue facing the field of psychedelic medicine: the recent FDA rejection of MAPS’ clinical trials to reschedule MDMA for therapeutic use. This setback affects many of...

28 Loka 20241h 3min

Tricia Eastman & Joseph Barsuglia: Ibogaine is Miracle Grow for the Brain

Today we’re doing something a little different. I’m re-releasing an episode from my personal podcast, Life is a Festival, because it remains one of my favorite interviews ever. This conversation, orig...

18 Loka 20241h 9min

Jennifer Tippett: Understanding Private Practice vs Clinical Trials

After the shocking decision of an advisory committee recommendation that the FDA reject MDMA as a treatment for post-traumatic stress disorder, I wanted to speak to someone who understands the differe...

8 Elo 202446min